NCT05553899 Utility of PET-MRI in Surveillance of Paediatric Brain Tumours
| NCT ID | NCT05553899 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sheffield Children's NHS Foundation Trust |
| Condition | Brain Tumor, Pediatric |
| Study Type | INTERVENTIONAL |
| Enrollment | 5 participants |
| Start Date | 2024-02-28 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 5 participants in total. It began in 2024-02-28 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a pilot project to explore the utility of PET-MRI in the post-treatment surveillance of high-grade gliomas or medulloblastomas in children in our institution.
Eligibility Criteria
Inclusion Criteria: * Have a presumptive or histologically confirmed diagnosis of a malignant brain tumour requiring treatment * Diagnostic uncertainty about tumour recurrence post-treatment based on conventional MR imaging in the opinion of the MDT * Have a life expectancy of at least three months * Able to comply with an MRI scan without a general anaesthetic Exclusion Criteria: * Unable to comply with an MRI scan without a general anaesthetic * Diabetes or other causes of hyperglycaemia * Pregnancy * Patient body habitus above scanner dimensions * Standard contra-indication to MRI (eg. pacemaker, non-compatible metallic implants, altered renal function)
Contact & Investigator
Ola Rominyi, MBChB
PRINCIPAL INVESTIGATOR
University of Sheffield
Frequently Asked Questions
Who can join the NCT05553899 clinical trial?
This trial is open to participants of all sexes, aged 8 Years or older, up to 18 Years, studying Brain Tumor, Pediatric. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05553899 currently recruiting?
Yes, NCT05553899 is actively recruiting participants. Contact the research team at d.king6@nhs.net for enrollment information.
Where is the NCT05553899 trial being conducted?
This trial is being conducted at Sheffield, United Kingdom.
Who is sponsoring the NCT05553899 clinical trial?
NCT05553899 is sponsored by Sheffield Children's NHS Foundation Trust. The principal investigator is Ola Rominyi, MBChB at University of Sheffield. The trial plans to enroll 5 participants.